Sai Life Sciences’ ₹3,042 crore IPO opens today, closing December 13. The offer includes a fresh issue and an OFS, aiming to repay debt. Priced at ₹522-549 per share, analysts advise caution due to high valuation and OFS-heavy structure, despite strong financial performance.
Paul Black’s 3 thumb rules for identifying great wealth creators
Veteran portfolio manager Paul Black’s investment framework focuses on identifying businesses with competitive advantages that strengthen over time. His three key rules emphasise widening moats,